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ABSTRACT 
 
Bifidobacterial species are widespread in gastrointestinal tracts of mammalian and other animals; 
they can be found in extra body environment only after a fecal contamination or human intentional 
addition (as the case of probiotics). Interestingly their occurrence is strictly linked to their hosts with 
a clear demarcation between animal and human species. PCR-restriction fragment length 
polymorphism (PCR-RFLP) on the 16S rRNA gene, using Alul, and TaqI restriction enzymes, have 
been utilized to distinguish the animal or human source of 64 strains belonging to 13 
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Bifidobacterium species (Delcenserie et al. [15]). Our aim was to test this method updating an in 
silico restriction analysis on the available 16S rRNA gene sequences of all 55 currently described 
taxa of Bifidobacterium genus. Our results confirmed the reliability of this method, optimized with the 
use of three restriction enzymes: Alul, TaqI and MaeIII, as a fast and simple strategy to determine 
the origin (human or animal) of bifidobacteria. Interestingly, the bifidobacterial species recently 
isolated from non-human primates cluster in the group of animal source except the bifidobacterial 
species isolated from higher non-human primates closest to humans such as apes (chimpanzee, 
orangutan and gorilla) that clusters with human group. Moreover, B. minimum, B. subtile and B. 
mongoliense isolated only from extrabody environment of which the source is unknown clustered 
with animal species. The in silico RFLP-PCR confirmed its powerful ability to attribute the primary 
source of occurrence (human or animal) for bifidobacterial species to the human or animal habitat. 
 
 
Keywords:  Bifidobacterium spp.; computer simulated RFLP; AluI; TaqI; MaeIII; host specificity; fecal 
contamination indicator. 
 
1. INTRODUCTION 
 
Bifidobacteria are an important group of intestinal 
commensals that exert a number of beneficial 
effects on their hosts such as prevention of 
diarrhea and microbial infection, alleviation of 
lactose intolerance and modulation of immune 
system [1]. Bifidobacteria are considered host-
species-specific bacteria as validated by 
numerous studies [1]. In human beings the 
following bifidobacterial species have been 
found: B. adolescentis, B. angulatum, B. bifidum, 
B. breve, B. catenulatum, B. dentium, B. 
gallicum, B. longum subsp. longum, B. longum 
subsp. infantis, B. pseudocatenulatum and B. 
scardovii [2]. Generally, the species present in 
humans are not present in the other vertebrates, 
except for the group described as B. longum-
infantis and for B. pseudocatenulatum, which are 
present in infants and suckling calves. 
Bifidobacteria have been isolated from many not-
human vertebrates, especially mammalian. Of 
the 55 bifidobacterial taxa described to date, 42 
have been isolated from not human vertebrates. 
[3]. Most of these species have a single host, 
e.g. B. magnum in rabbit, B. choerinum in pig 
and B. pullorum in chicken. Moreover, some 
species are present in more than one host, like 
the B. animalis subsp. lactis isolated from rabbit 
and chicken, B. thermophilum from chicken, pig, 
calf and bovine rumen and B. pseudolongum 
subsp. globosum and subp. pseudolongum 
(chicken, rabbit, pig, calf and bovine rumen, rat). 
Bifidobacteria typically found in insects are: B. 
actinocoloniforme, B. bohemicum, B. bombi, B. 
asteroides, B. coryneofrme and B. indicum. 
Finally in non human primates, except Apes, the 
following species have been found: B. aesculapii, 
B. biavati, B. callitrichos, B. eulemuris, B. 
lemurum, B. reuteri, B. stellenboschense, B. 
myosotis, B. tissieri, B. hapali, B. moukalabense 
[4–10]. On the other hand, in Apes, such as 
orangutan and chimpanzee, the bifidobacteria 
typical of human habitat “Bifidobacterium 
angulatum like”, B. dentium and B. adolescentis 
have been found [11,12,13]. 
 
Eventually B. minimum and B. subtile being 
isolated from sewage cannot be attributed to a 
specific animal or human host source. The very 
peculiar feature of species specific bifidobacterial 
distribution in gastrointestinal tracts of their hosts 
can be a valuable tool for individuating the 
source of faecal contamination in water 
environments or along the meat processing chain 
[14]. For these applications the development and 
implementation of tools which can attribute the 
primary source of bifidobacterial species of 
unknown origin is of great importance in order to 
determine the original source of bifidobacterial 
species. The discriminatory power of rRNA gene 
analysis utilized for species identification can be 
improved by digestion of PCR products, and 
analysis of restriction fragment length 
polymorphism (PCR – RFLP) after gel 
electrophoresis [15] in order to identify the 
human or animal origin of the strains. For the first 
time Delcenserie et al. [16] after designing 
specific PCR primers matching the 16S rDNA 
region performed a study of sixty-four strains 
belonging to thirteen Bifidobacterium species by 
means of the Alul enzyme. This restriction 
allowed them to obtain seven different groups. 
However, because two groups contained both 
animal and human strains, the TaqI enzyme was 
then used to correctly differentiate the origin of 
those strains. The current availability of a large 
number of bifidobacterial 16S rRNA sequences 
makes possible to simulate restriction digestions 
in silico and to generate virtual RFLP patterns for 
high throughput study of these bacteria. Here, we 
report the exploitation of a computer-simulated 
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RFLP analysis method, performing an in silico 
restriction analysis on the available 16S rRNA 
gene sequences, with the aim to verify the 
reliability of this method in differentiating from 
animal or human origin of the currently described 
55 bifidobacterial taxa. 
 
2. MATERIALS AND METHODS   
 
2.1 Bifidobacterium 16S rRNA Partial 
Gene Sequences  
  
The 16S rRNA gene sequences of the 
55bifidobacterial taxa were retrieved from the 
NCBI database (http://www.ncbi.nlm.nih.gov/) 
and listed in Table 1. We also included the 16S 
rRNA gene sequences of three novel 
bifidobacterial taxa recently isolated from non-
human primates. All the sequences were first 
aligned in CLC_Sequence Viewer version 7.5, for 
Mac OS (CLC, Inc., Aarhus, Denmark) using 
Clustal Omega and then edited in the region 
flanked by primers 16S direct, 5’ – AAT AGC 
TCC TGG AAA CGG GT – 3’, and 16S reverse, 
5’ - CGT AAG GGG CAT GAT GAT CT – 3’ [14]. 
Final sequences of about 1050 bp were 
obtained. 
 
2.2 Restriction Enzyme Analysis 
 
All restriction analyses were performed in silico 
using the tool Restriction Site Analysis available 
in CLC_Sequence Viewer version 7.5, for Mac 
OS (CLC, Inc., Aarhus, Denmark). According to 
the method proposed by Delcenserie et al. [15], 
as first step, the 16S rRNA partial gene 
sequences were digested with Alul. Each pattern 
was analysed and compared to the groups 
previously described and associated with the 
different origin by Delcenserie et al. [16], using a 
script written in Python (version 2.7.8) 
(https://www.python.org/) (Supplementary File 1) 
for this study. If an unknown restriction profile 
was obtained, it was labelled as New Profile (NP) 
and the origin of the corresponding 
bifidobacterial species was recognized. When a 
heterogeneous pattern was obtained, the 
corresponding 16S rRNA gene sequences were 
restricted with TaqI and successively, if 
necessary, with MaeIII until a correct origin was 
obtained. 
 
Table 1. List of species (all type strains if not specified), origin, international collection and 
GenBank accession number and fragment size (in bp) for each partial 16S rRNA gene 
sequence used in this study 
 
Species Origin Collection Nr.  GenBank 
accession 
Nr. 
16S rRNA 
fragment 
size (bp) 
B. actinocoloniforme Animal DSM 22766 FD858731 1054 
B. adolescentis Human DSM 20089  AB437355 1056 
B. aesculapii Animal DSM 26737  KC807989 1055 
B. angulatum Animal AATCC 27535 D86182 1054 
B. animalis subsp. animalis Animal JCM 1190  D86185 1066 
B. animalis subsp. lactis Animal DSM 10140  AB050136 1064 
B. asteroides Animal DSM 20089  EF187235 1052 
B. biavatii Animal DSM 23969  AB559506 1062 
B. bifidum Human DSM 20456  AB437356 1054 
B. bohemicum Animal DSM 22767 FD858736 1053 
B. bombi Animal DSM 19703  HE582780 1051 
B. boum Animal JCM 1211  D86190 1054 
B. breve Human AATCC 15700  AB006658 1056 
B. callitrichos Animal DSM 23973  AB559503 1051 
B. catenulatum Animal DSM 16992  AB437357 1054 
B. choerinum Animal AATCC 27686 D86186 1064 
B. commune Animal DSM 28792  LK054489 1051 
B. coryneforme Animal DSM 20216  AB437358 1052 
B. crudilactis Animal DSM 20435  NR_115342 1050 
B. cuniculi Animal DSM 20435  AB438223 1065 
B. dentium Human AATCC 27534 D86183 1056 
B. faecal Animal JCM 19861  KF990498 1055 
B. gallicum Animal JCM 8224  D86189 1064 
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Species Origin Collection Nr.  GenBank 
accession 
Nr. 
16S rRNA 
fragment 
size (bp) 
B. gallinarum Animal JCM 6291  D86191 1050 
B. hapali Animal JCM 30799 KP7189460 1057 
B. hapali Animal JCM 30800 
(Reference Strain) 
KP7189462 1055 
B. indicum Animal JCM 1302  D86188 1052 
B. kashiwanohense Animal DSM 21854  NR_112779 1053 
B. lemurum Animal DSM 28807  KJ658281 1052 
B. eulemuris Animal JCM 30801  KP979748 1051 
B. longum subsp. infantis Human ATCC 15697  D86184 1051 
B. longum subsp. longum Human ATCC 55813 DB437359 1051 
B. longum subsp. suis Animal ATCC 27533  M58743 1051 
B. magnum Animal JCM 1218  D86193 1062 
B. merycicum Animal JCM 8219  D86192 1054 
B. minimum Animal DSM 20102  AB437350 1051 
B. mongoliense Animal DSM 21395  AB433856 1051 
B. moukalabense Animal JCM 18751  AB821293 1059 
B. myosotis Animal JCM 30796 KP718941 1051 
B. myosotis Animal JCM 30797  
(Reference Strain) 
KP718942 1051 
B. pseudocatenulatum Human JCM 1200  D86187 1054 
B. pseudolongum subsp. 
globosum 
Animal DSM 20092  M58736 1065 
B. pseudolongum subsp. 
pseudolongum 
Animal JCM 1205  D86195 1064 
B. psychraerophilum Animal DSM 22366  AB437351 1050 
B. pullorum Animal JCM 1214  D86196 1051 
B. reuteri Animal DSM 23975  AB613259 1054 
B. ruminantium Animal JCM 8222  D86197 1056 
B. saeculare Animal DSM 6531  D89328 1051 
B. saguini Animal DSM 23967  AB559504 1052 
B. scardovii Human DSM 13734  N180852 1052 
Bifidobacterium spp.  Animal BUSCOB 
MRM_8.19 
KP7189459 1054 
Bifidobacterium spp.  Animal BUSCOB 
MRM_9.3 
KP7189460 1053 
B. stellenboschense Animal DSM 23968  AB559505 1060 
B. subtile Animal DSM 20096  D89378 1052 
B. thermacidophilum subsp. 
porcinum 
Animal DSM 17755  AB437361 1054 
B. thermacidophilum subsp. 
thermacidophilum 
Animal DSM 15837  AB437362 1054 
B. thermophilum Animal DSM 20210  AB437364 1054 
B. tissieri Animal JCM 30798T KP7189451 1053 
B. tissieri Animal JCM 30803 
(Reference Strain) 
KP7189457 1053 
B. tsurumiense Animal DSM 17777  AB241106 1056 
DSM, Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; JCM, Japan Collection of 
Microorganisms; BUSCOB, Bologna University Scardovi Collection of Bifidobacteria 
 
3. RESULTS  
 
Computer-simulated analysis is revolutionising 
some of the manners in which microbiological 
research is carried out. In silico approaches do 
not require any expensive materials (i.e., 
chemicals and enzymes) and analytical 
instruments and facilitate and speed up the 
screening of several strains rapidly and provide a 
better vision of microbial ecology [17]. The 
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restriction analysis of the 16S rRNA partial gene 
sequence with Alul and TaqI had been described 
as an easy way to distinguish human from animal 
borne bifidobacteria [15]. The method was 
previously tested on sixty-four strains belonging 
to only 13 Bifidobacterium species [15], but 
nowadays, 50 bifidobacterial species and 6 
subspecies have been validated. To verify the 
reliability of this method, an in silico restriction 
analysis was performed on the 16S rRNA partial 
gene sequences of the 55 validated type strains. 
We also included two strains belonging to two 
putative novels Bifidobacterium species isolated 
from baby common marmosets [8]. All the 
aligned 1050 bp sequences, belonging to the 57 
bifidobacterial type strain, were firstly digested 
with the enzyme Alul (Table 2) and thirteen 
different patterns were obtained. Seven pattern 
out of the thirteen described were found also by 
Delcenserie et al. [15] while for the other ones 
they were labelled as New Profile and added in 
the Python script, which resulted able to rapidly 
calculate each restriction profile and to associate 
them to the respective group (Table 2). The 
following pattern are shown: pattern I (800– 150–
100 bp) included B. animalis subsp. animalis,              
B. animalis subsp. lactis, B. cuniculi, B. 
stellenboschense, B. aesculapii, B. reuteri and B. 
adolescentis; pattern II (600–200– 150–100 bp) 
included B. asteroides, B. scardovii, B. 
acticolooniforme, B. tsurumiense, B. tissieri,               
B. kashiwanohense, B. biavatii, B. choerinum,     
B. pseudolongum subsp. globosum, B. 
pseudolongum subsp. pseudolongum, B. 
bifidum, B. breve, and B. dentium, strains 
Bifidobacterium spp. MRM 8.19 and 
Bifidobacterium spp. MRM 9.3; pattern III (400–
300–200–150 bp) includedB. merycicum, B. 
angulatum and B. callitrichos; pattern IV (900–
150 bp) included B. ruminantium; pattern V (310–
290–200–150– 100 bp) included B. minimum, B. 
indicum, B. coryneforme, B. commune, B. 
subtile, B. crudilactis, B. psychraerophilum, B. 
mongoliense; pattern VI (700–200–150 bp) 
included B. pseudocatenulatum, B. catenulatum 
and B. moukalabense; and pattern VII (800–150–
50–30) included B. thermophilum, B. boum, B. 
thermoacidophilum subsp. thermoacidophilum, 
B. thermoacidophilum subsp. porcinum, B. 
saguini, B. faecale. The following new patterns 
were shown: pattern I-NP (492-406-146-6), IV-
NP (310-246-107-145-102-40), V-NP (352-311-
286-60-35-6) and VI-NP (375-233-206-134-96) 
each included one species: B. myosotis (type 
and reference strains), B. bohemicum, B. 
lemurum and B. gallicum, respectively. 
Furthermore, group III-NP (315-286-206-140-60-
37) included three animal species: B. bombi, 
isolates from insects, B. hapali (type and 
reference strains), recently isolated from baby 
common marmosets and B. eulemuris, a novel 
species isolated from the black lemur. However, 
pattern II-NP (590/600-206-145-60-35-6 bp) 
included B. longum subsp. suis, B. magnum, B. 
pullorum, B. saeculare, B. longum subp. infantis, 
B. longum subsp. longum and B. gallinarum, then 
resulting heterogeneous. Therefore, restriction 
with Alul generated four heterogeneous groups 
(I, II, the new II-NP and the VII pattern, 
previously described by Delcenserie et al. [15] as 
homogenous differently from this study) as 
including species of both human- and animal 
borne bifidobacteria. As the aim of the present 
study was to set up a method to distinguish 
bifidobacteria with respect to their origin, the 
second enzyme TaqI has been utilized for 
restriction of the 16S rRNA sequences clustered 
in all heterogeneous profiles. Resulting profiles 
were elaborated with the Python script: two 
patterns, VIII and IX, previously identified and 
associated with the different origin by 
Delcenserie et al. [15] were retrieved together 
with the two new profiles X-NP and XI-NP (Table 
3). Based on the new fragment length profiles 
calculated, species of group I, II and II-NP were 
reassigned to groups VIII and IX, X-NP and XI-
NP (Table 3). Groups VIII and X-NP resulted 
homogeneous as including only species of 
animal origin: group VIII (471-340-240) included 
B. animalis susbp. animalis, B. animalis subsp. 
lactis, B. choerinum, B. cuniculi, B. 
pseudolongum subsp. pseudolongum, and B. 
pseudolongum subsp. pseudolongum while 
group X-NP (800-250 bp) included two animal 
species recently described in common 
marmoset, B. reuteri and B. aesculapii. Group IX 
(471-250-198-134) resulted heterogeneous as 
containing bifidobacterial species from human 
and animal origin such as B. asteroides, B. 
adolescentis, B. breve, B. kashiwanohense, B. 
bifidum, B. dentium, and B. magnum. The same 
for the group XI-NP (666-253-133) including B. 
gallinarum, B. longum subsp. longum, B. longum 
subsp. infantis, B. longum subsp. suis, B. 
saeculare, B. pullorum, B. actinocoloniforme, B. 
biavati. Analysing all the currently described 
species of bifidobacteria, TaqI was not able to 
correctly differentiate origin of some species in 
the groups II and II-NP (Table 3). Therefore, the 
16S rRNA sequences in those groups were 
further restricted by means of other several 
enzymes available in the CLC_Sequence Viewer 
database. Only the enzyme MaeIII resulted able 
to distinguish human from animal borne 
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bifidobacteria and five homogenous groups    
were obtained: group X (372-275-185-157-61) 
including B. biavatii, group XI (468-364-157-61) 
including B. actinocoloniforme, group XII (471-
405-113-61) containing B. longum subsp. longum 
and B. longum subsp. infantis, group XIII (518-
472-61) containing B. scardovii, B. gallinarum, B. 
pullorum and B. saeculare, group XIV (532-405-
113) only containing B. longum subsp. suis of 
animal origin (Table 4). Table 5 summarized 
results obtained from the restriction analysis with 
the three enzymes used sequentially. 
 
Table 2. Alul_I restriction profiles obtained for each species with information about the pattern 
attribution and the origin 
 
Sequence Frag
1 
Frag
2 
Frag
3 
Frag
4 
Frag
5 
Frag
6 
Alul_I 
pattern 
Origin 
B. animalis subsp. lactis 814 134 96 6   I Human or 
Animal 
B. cuniculi 814 133 97 6   I Human or 
Animal 
B. animalis subsp. 
animalis 
815 132 97 6   I Human or 
Animal 
B. stellenboschense 810 137 97 6   I Human or 
Animal 
B. aesculapii 806 142 96 6   I Human or 
Animal 
B. adolescentis 806 142 96 6   I Human or 
Animal 
B. reuteri 804 144 96 6   I Human or 
Animal 
B. myosotis 492 406 146 6   I-NP Animal 
(Common 
marmoset) 
B. myosotis (reference 
strain) 
492 406 146 6   I-NP Animal 
(Common 
marmoset) 
B. asteroides 596 206 146 96 6  II Human or 
Animal 
B. scardovi 598 206 145 95 6  II Human or 
Animal 
Bifidobacterium spp. 
MRM_8.19 
598 206 144 96 6  II Human or 
Animal 
B. actinocoloniforme 598 206 144 102 0  II Human or 
Animal 
B. tsurumiense 600 206 142 96 6  II Human or 
Animal 
Bifidobacterium spp. 
MRM_9.3 
597 206 144 97 6  II Human or 
Animal 
B. tissieri  597 206 145 96 6  II Human or 
Animal 
B. tissieri (reference 
strain) 
597 206 145 96 6  II Human or 
Animal 
B. dentium 600 206 142 96 6  II Human or 
Animal 
B. bifidum 598 206 144 96 6  II Human or 
Animal 
B. kashiwanohense 598 206 145 95 6  II Human or 
Animal 
B. biavati 606 206 136 96 6  II Human or 
Animal 
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Sequence Frag
1 
Frag
2 
Frag
3 
Frag
4 
Frag
5 
Frag
6 
Alul_I 
pattern 
Origin 
B. pseudolongum subsp.  
globosum 
608 206 133 97 6  II Human or 
Animal 
B. choerinum 608 206 134 96 6  II Human or 
Animal 
B. pseudolongum subsp. 
pseudolongum 
608 206 134 96 6  II Human or 
Animal 
B. breve 601 206 142 95 6  II Human or 
Animal 
B. longum subsp. longum 596 206 147 60 35 6 II-NP Human or 
Animal 
B. gallinarum 595 206 148 60 35 6 II-NP Human or 
Animal 
B. saeculare 596 206 147 60 35 6 II-NP Human or 
Animal 
B. longum subsp.suis 596 206 147 60 35 6 II-NP Human or 
Animal 
B. longum subsp.infantis 596 206 147 60 35 6 II-NP Human or 
Animal 
B. pullorum 596 206 147 60 35 6 II-NP Human or 
Animal 
B. magnum 607 206 136 60 35 6 II-NP Human or 
Animal 
B. merycicum 408 286 206 144 6  III Animal 
B. callitrichos 405 286 206 147 6  III Animal 
B. angulatum 408 286 206 144 6  III Animal 
B. hapalii 315 286 206 140 60 37 III-NP Animal 
B. hapalii (reference 
strain) 
313 286 206 142 60 37 III-NP Animal 
B. bombi 310 286 206 147 60 35 III-NP Animal 
B. eulemuris 310 286 206 147 60 35 III-NP Animal 
B. ruminantium 902 142 6    IV Animal 
B. bohemicum 310 246 207 145 102 40 IV-NP Animal 
B. mongoliense 310 286 206 147 95 6 V Animal 
B. psychraerophilum 310 285 206 148 95 6 V Animal 
B. crudilactis 310 285 206 148 95 6 V Animal 
B. subtile 310 286 206 146 96 6 V Animal 
B. commune 310 286 206 147 95 6 V Animal 
B. coryneforme 310 286 206 146 96 6 V Animal 
B. minimum 310 286 206 147 95 6 V Animal 
B. indicum 310 286 206 146 96 6 V Animal 
B. lemurum 352 311 286 60 35 6 V-NP Animal 
B. moukalabense 699 206 139 6   VI Human 
B. pseudocatenulatum 694 206 144 6   VI Human 
B. catenulatum 694 206 144 6   VI Human 
B. gallicum 375 233 206 134 96  VI-NP Human 
B. thermophilum 805 144 60 35 6  VII Animal 
B. boum 805 144 60 35 6  VII Animal 
B.thermacidophilum 
subsp. thermacidophilum 
805 144 60 35 6  VII Animal 
B. thermacidophilum 
subsp. porcinum 
805 144 60 35 6  VII Animal 
B. saguini 804 145 60 35 6  VII Animal 
B. faecale 806 143 60 35 6  VII Animal 
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Table 3. TaqI restriction profiles obtained for each species with information about the pattern 
attribution and the origin. For each species, type strains have been utilized; only for B. tissieri, 
B. hapali and B. myosotis also the reference strains have been used 
 
Species Frag
1 
Frag  
2 
Frag  
3 
Frag  
4 
TaqI 
Pattern 
Origin 
B. animalis subsp. animalis 0 238 341 471 VIII Animal 
B. animalis subsp. lactis 0 240 339 471 VIII Animal 
B. boum 0 250 330 470 VIII Animal 
B. choerinum 0 240 339 471 VIII Animal 
B. cuniculi 0 239 340 471 VIII Animal 
B. pseudolongum subsp. globosum 0 239 340 471 VIII Animal 
B. pseudolongum subsp. 
pseudolongum 
0 240 339 471 VIII Animal 
B. saguini 0 251 328 471 VIII Animal 
B. tissieri 0 251 328 471 VIII Animal 
B. tissieri (reference strain) 0 251 328 471 VIII Animal 
Bifidobacterium spp. MRM_8.19 0 250 329 471 VIII Animal 
Bifidobacterium spp. MRM_9.3 0 250 328 472 VIII Animal 
B. asteroides 134 193 252 471 IX reconsidered 
as Human or 
Animal 
B. dentium 134 197 248 471 IX reconsidered 
as Human or 
Animal 
B. bifidum 134 195 250 471 IX reconsidered 
as Human or 
Animal 
B. breve 133 198 248 471 IX reconsidered 
as Human or 
Animal 
B. adolescentis 134 197 248 471 IX reconsidered 
as Human or 
Animal 
B. faecal 133 197 249 471 IX reconsidered 
as Human or 
Animal 
B. kashiwanohense 133 195 251 471 IX reconsidered 
as Human or 
Animal 
B. tsurumiense 134 197 248 471 IX reconsidered 
as Human or 
Animal 
B. magnum 133 204 242 471 IX reconsidered 
as Human or 
Animal 
B. thermophilum 133 197 250 470 IX reconsidered 
as Human or 
Animal 
B. thermacidophilum subsp. 
thermacidophilum 
133 197 250 470 IX reconsidered 
as Human or 
Animal 
B. thermacidophilum subsp. 
porcinum 
133 197 250 470 IX reconsidered 
as Human or 
Animal 
B. aesculapii 0 0 249 801 X-NP Animal 
(Monkey) 
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Species Frag
1 
Frag  
2 
Frag  
3 
Frag  
4 
TaqI 
Pattern 
Origin 
B. reuteri 0 0 250 800 X-NP Animal 
(Monkey) 
B. longum subsp. suis 0 133 253 664 XI-NP Animal or 
Human 
B. longum subsp. infantis 0 133 253 664 XI-NP Animal or 
Human 
B. longum subsp. longum 0 133 253 664 XI-NP Animal or 
Human 
B. actinocolinoforme 0 134 250 666 XI-NP Animal or 
Human 
B. scardovii 0 133 251 666 XI-NP Animal or 
Human 
B. stellenboschense 0 135 243 672 XI-NP Animal or 
Human 
B. biavatii 0 134 242 674 XI-NP Animal or 
Human 
B. gallinarum 0 133 254 663 XI-NP Animal or 
Human 
B. pullorum 0 133 253 664 XI-NP Animal or 
Human 
B. saeculare 0 133 253 664 XI-NP Animal or 
Human 
 
Table 4. MaeIII restriction profiles obtained for each species with information about the pattern 
attribution and the origin 
 
Species Frag  
1 
Frag  
2 
Frag  
3 
Frag  
4 
Frag 
5 
Frag  
6 
MaeIII 
pattern 
Origin 
B. biavatii 61 157 185 275 372 0 X Animal 
B. actinocolinoforme 0 61 157 364 468 0 XI Animal 
B. adolescentis 0 61 114 409 466 0 XII Human 
B. breve 0 61 113 410 466 0 XII Human 
B. dentium 0 61 114 409 466 0 XII Human 
B. faecal 0 61 113 409 467 0 XII Human 
B. bifidum 0 61 114 407 468 0 XII Human 
B. kashiwanohense 0 61 113 407 469 0 XII Human 
B. longum subsp. longum 0 61 113 405 471 0 XII Human 
B. longum subsp. infantis 0 61 113 405 471 0 XII Human 
B. stellenboschense 0 0 61 461 528 0 XIII Animal 
B. tsurumiense 0 0 61 466 523 0 XIII Animal 
B. thermacidophilum subsp. 
porcinum 
0 0 61 467 522 0 XIII Animal 
B. thermophilum 0 0 61 467 522 0 XIII Animal 
B. thermacidophilum subsp. 
thermacidophilum 
0 0 61 467 522 0 XIII Animal 
B. pullorum 0 0 61 471 518 0 XIII Animal 
B. scardovii 0 0 61 469 520 0 XIII Animal 
B. asteroides 0 0 61 470 519 0 XIII Animal 
B. saeculare 0 0 61 471 518 0 XIII Animal 
B. stellenboschense 0 0 61 461 528 0 XIII Animal 
B. gallinarum 0 0 61 472 517 0 XIII Animal 
B. magnum 0 0 113 416 521 0 XIV Animal 
B. longum subsp. suis 0 0 113 405 532 0 XIV Animal 
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Table 5. Summary of the results obtained from the restriction analysis with the three enzymes 
 
Species Origin First 
digestion:  
AlulI pattern 
Second 
digestion: TaqI 
pattern 
Third digestion: 
MaeIII pattern 
B. biavatii Animal II XI-NP X 
B. actinocolinoforme Animal II XI-NP XI 
B. adolescentis Human I IX XII 
B. kashiwanohense Human II IX XII 
B. dentium Human II IX XII 
B. breve Human II IX XII 
B. bifidum Human II IX XII 
B. faecale Human VII IX XII 
B. longum subsp. longum Human II-NP XI-NP XII 
B. longum subsp. infantis Human II-NP XI-NP XII 
B. tsurumiense Animal II IX XIII 
B. asteroides Animal II IX XIII 
B. thermophilum Animal VII IX XIII 
B. thermacidophilum subsp. 
thermacidophilum 
Animal VII IX XIII 
B. thermacidophilum subsp. 
porcinum 
Animal VII IX XIII 
B. stellenboschense Animal I XI-NP XIII 
B. scardovii Animal II XI-NP XIII 
B. saeculare Animal II-NP XI-NP XIII 
B. pullorum Animal II-NP XI-NP XIII 
B. gallinarum Animal II-NP XI-NP XIII 
B. magnum Animal II-NP IX XIV 
B. longum subsp. suis Animal II-NP XI-NP XIV 
B. cuniculi Animal I VIII  
B. animalis subsp. lactis Animal I VIII  
B. animalis subsp. animalis Animal I VIII  
B. tissieri Animal II VIII  
B. tissieriT Animal II VIII  
Bifidobacterium spp. 
MRM_8.19 
Animal II VIII  
Bifidobacterium spp. MRM_9.3 Animal II VIII  
B. pseudolongum subsp. 
pseudolongum 
Animal II VIII  
B. pseudolongum 
subsp.globosum 
Animal II VIII  
B. choerinum Animal II VIII  
B. saguini Animal VII VIII  
B. boum Animal VII VIII  
B. reuteri Animal I X-NP  
B. aesculapii Animal I X-NP  
B. myosotisT Animal I-NP   
B. myosotis MRM_5.10 Animal I-NP   
B. merycicum Animal III   
B. callitrichos Animal III   
B. angulatum Animal III   
B. eulemuris Animal III-NP   
B. hapalii Animal III-NP   
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Species Origin First 
digestion:  
AlulI pattern 
Second 
digestion: TaqI 
pattern 
Third digestion: 
MaeIII pattern 
B. hapaliiT Animal III-NP   
B. bombi Animal III-NP   
B. ruminantium Animal IV   
B. bohemicum Animal IV-NP   
B. subtile Animal V   
B. psychraerophilum Animal V   
B. mongoliense Animal V   
B. minimum Animal V   
B. indicum Animal V   
B. crudilactis Animal V   
B. coryneforme Animal V   
B. commune Animal V   
B. lemurum Animal V-NP   
B. pseudocatenulatum Human VI   
B. moukalabense Human VI   
B. catenulatum Human VI   
B. gallicum Human VI-NP   
 
4. DISCUSSION 
 
Bifidobacteria exert a positive health action 
towards target hosts such as human beings and 
other animals and literature supporting their 
beneficial use [3]. Characteristically 
Bifidobacterium species are characterized by 
significant host specificity. Based on this 
hypothesis, PCR methods have been utilized for 
detecting bifidobacteria as general indicators of 
faecal human or animal contamination in water 
pollution, in raw milk and raw milk cheese 
processes [16].  
 
In the present study the method described by 
Delcenserie et al. [15] using at first step AluI then 
TaqI with implementation of a third restriction 
step with MaeIII was applied to all bifidobacterial 
species nowadays described and confirmed its 
ability to differentiate their human or animal 
origin. 
 
Interestingly B. angulatum up to now considered 
of human origin, in this study clusters with B. 
merycicum and B. callithricos both from animal 
origin. This supports the hypothesis that finding a 
species with only one strain in one single habitat 
is not sufficient to ascribe this habitat to that 
species. Infact this species has been isolated 
from human faeces but probably derived from 
another source. Similarly B. scardovii which has 
been isolated from female adult patients, viz. 
from 50-year-old female’s blood sample in 
Sweden, from two elderly Swedish patients’ urine 
sample, and from a 44- year-old female patient’s 
hip [18], cluster with other animal species: also 
the source of this species probably need to be 
revised. Another interesting finding is the 
clustering of B. moukalabense, isolated from 
gorilla, a primate very close to humans, to human 
bifidobacterial group: the occurrence of human 
bifidobacterial species in apes has been yet 
described with the presence of B. adolescentis 
and B. dentium in chimpanzee, orangutan and 
gorilla [11,12]; on the other hand all the other 
recently describe species from primates, 
belonging to Old and New World monkeys and to 
Prosimians, which are at evolutionary level more 
distant from humans, cluster in the animal group 
of bifidobacteria. 
 
The use of bifidobacteria as indicators could be a 
powerful potential tool for the detection of 
antropic or livestock faecal contamination.RFLP-
PCR beside confirming the ecological habitat of 
the species that have been isolated from different 
animals and humans, is also able to attribute the 
niche to species of unknown origin: infact in the 
present work B. minimum and B. subtile isolated 
from sewage and B. mongoliense from 
fermented milk have been associated to animal 
source. Moreover, bifidobacteria isolated from 
primates are divided in two groups, where the 
species isolated from apes (orangutan, gorilla 
and chimpanzee) are associated to human 
source (B. moukalabense for instance cluster 
with human species) differently from all other 
bifidobacterial primate species (B. aerophilum, B. 
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avesanii, B. biavatii, B. callithricos, B. hapali, B. 
myosotis, B. ramosum, B. saguini, B. 
stellenboshense and B. tissieri), which cluster 
with animal sources. 
 
In silico RFLP analysis is very efficient also to 
discriminate bifidobacterial subspecies origin 
confirming B. longum subsp. longum and B. 
longum subsp. infantis typically found in humans 
different from B. longum subsp. suis and B. 
longum subsp. suillum typically found in animals. 
  
Further investigation by comparative genomics 
could probably better explain the link between 
genetic restriction profiles and specific niche 
distribution of bifidobacteria. 
 
5. CONCLUSION 
 
In the present work the application of PCR-RFLP 
for a rapid molecular recognition of natural 
habitat of bifidobacteria has been shown. This 
method with restriction databases of other strains 
belonging to Bifidobacteriaceae family would be 
an extremely useful and practical tool for 
application in microbial ecology studies. 
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